The Sync Up Podcast: Buy vs. build in life sciences
Episode 5: How to choose between building, buying, or hybrid integration strategies for clinical interoperability
Overview
Welcome to The Sync Up Podcast, where we explore how interoperability, integration, and connected data are transforming life sciences—from faster clinical trials to smarter, data-driven decisions.
In episode 5, we explore one of the most critical decisions organizations face—whether to buy or build integration solutions. Infor™ VP of Enterprise Interoperability, Jeff Mueller, and Infor Senior Account Manager, Alexis Moores, are once again joined by Roche Global Digital Partnering Lead and Strategy Manager, Dom Bourgeon, to discuss:
- Pros and cons of building vs. buying integration solutions, including control, cost, and scalability
- Hybrid strategies that blend internal expertise with vendor solutions for optimal outcomes
- Real-world return on investment (ROI) considerations such as time-to-market, downtime risks, and long-term support
Designed for life sciences professionals, data enthusiasts, and anyone passionate about healthcare technology, The Sync Up offers practical tools and strategies to elevate your data approach.
Don’t miss this opportunity to stay ahead in the life sciences industry.
At Infor Cloverleaf™, we enable seamless connectivity across the life sciences landscape. Our interoperability solutions help organizations create integrated ecosystems, accelerate trials, and improve outcomes—turning challenges into opportunities.